Tag: FDA approval
Understanding the Hatch-Waxman Act: How US Generic Drug Policy Works
Explore how the Hatch-Waxman Act balances drug innovation with generic competition, shaping the US pharmaceutical market and FDA approval processes.
Recent Patent Cases and Generic Delays: 2023-2025 Examples
Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years before reaching patients due to patent litigation. Learn how brand-name companies use legal tactics to block affordable alternatives - and who pays the price.